Drugs / NAMITECAN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01748019 | Jun 2007 → Jun 2011 | cancer | sigma-tau i.f.r. S.p.A. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAMITECAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL606805 ↗ |
| Known as | ST1968 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01748019 ↗ |
| Modality | Small molecule | — CHEMBL606805 ↗ |
| Route | Intravenous | “ST1968 given intravenously (I.V.) once every week for 2 consecutive weeks every 3 weeks” NCT01748019 ↗ |